Recherche
-
Therapeutic Patient Education for Fibromyalgia during Spa Therapy: The FiETT Randomized Controlled Trial
(International Journal of Environmental Research and Public Health. vol. 19, n° 8, 2022-04-11)Article de revueLibre accès -
A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case
(Journal of The American Society for Mass Spectrometry. vol. 33, n° 10, pp. 1975-1981, 2022-10-05)Article de revue -
2PRESCRIBE AS INTERNATIONAL AND DIGITAL CASE-BASED PHARMACOTHERAPY EDUCATION AND RESEARCH PLATFORM
(European Journal of Clinical Pharmacology. vol. 78, n° SUPPL 1, pp. S50-S50, 2022-06)Article de revue -
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
(Blood. vol. 139, n° 16, pp. 2561-2565, 2022-04-21)Article de revue -
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases
(Drug Safety, 2022-02-18)Article de revue -
The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
(Respiratory Research. vol. 23, n° 1, pp. 214, 2022-08-23)Article de revueLibre accès -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès